Form4insider filings, from the source

SEC Form 4 · accession 0000902664-15-003962

FIVE PRIME THERAPEUTICS INC · FPRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Phillip Gross
10% Owner
Period of report
Oct 15, 2015
Accepted (ET)
Oct 19, 2015 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.001 ("Common Stock")F1Oct 15, 2015S9,313$28.02D2,655,636ISee footnote
Common StockF1Oct 15, 2015S65,687$27.58D2,589,949ISee footnote
Common StockF1Oct 15, 2015S25,000$28.85D2,564,949ISee footnote
Common StockF1Oct 15, 2015S25,000$27.00D2,539,949ISee foonote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses